Unidad de Revisiones Sistemáticas y Meta-análisis

Medicina y ciencias biológicas

1. Systematic Reviews 100%
2. Meta-Analysis 83%
3. Coronavirus 43%
4. Peru 40%
5. Confidence Intervals 38%
6. Randomized Controlled Trials 32%
7. Mortality 24%
8. Hydroxychloroquine 24%
9. Latin America 23%
10. Dyspepsia 19%
11. Odds Ratio 17%
12. Pancreatitis 14%
13. Pandemics 13%
14. Hemorrhage 13%
15. Helicobacter pylori 13%
16. Lipids 12%
17. Intention 12%
18. Therapeutics 12%
19. Network Meta-Analysis 10%
20. Hydroxymethylglutaryl-CoA Reductase Inhibitors 10%
21. Coronary Artery Disease 10%
22. APACHE 9%
23. Vaccination 9%
24. Melena 8%
25. Hematemesis 8%
26. Cohort Studies 8%
27. Autoimmune Hepatitis 8%
28. Choriocarcinoma 8%
29. Pericarditis 8%
30. Social Security 8%
31. Gastroenterology 8%
32. Gastrointestinal Endoscopy 8%
33. Biopsy 8%
34. Public Hospitals 7%
35. Databases 7%
36. Chloroquine 7%
37. Shock 7%
38. Endoscopy 7%
39. Observational Studies 7%
40. Depression 7%
41. Case-Control Studies 7%
42. Lopinavir 6%
43. Dietary Supplements 6%
44. Neoplasms 6%
45. Acute Coronary Syndrome 6%
46. Placebos 6%
47. Virus Diseases 6%
48. Azithromycin 6%
49. Hospitalization 6%
50. Dietary Animal Proteins 6%
51. Hepatitis 6%
52. Practice Guidelines 6%
53. Ritonavir 6%
54. Lymphocytes 6%
55. Food Supply 6%
56. Infections 6%
57. Atrial Fibrillation 5%
58. origen 5%
59. Intensive Care Units 5%
60. Safety 5%
61. Stomach 5%
62. Intestinal Lymphangiectasis 5%
63. Human T-lymphotropic virus 1 5%
64. Percutaneous Coronary Intervention 5%
65. Myocardial Infarction 5%
66. Hypertension 5%
67. Nocebo Effect 5%
68. Cross-Sectional Studies 5%
69. Vulvodynia 5%
70. Eosinophilic enteropathy 5%
71. Spirulina 5%
72. Anti-Inflammatory Agents 5%
73. Parents 5%
74. Restrictive Cardiomyopathy 5%